- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Caplin Steriles (subsidiary) received USFDA final approval for Milrinone Lactate in 5% Dextrose Injection. This generic targets acute decompensated heart failure and addresses a US market with approximately $11 million in annual sales, boosting the company's sterile injectables portfolio.